Genetic Testing For Cancer Presents Complex Challenges

HARD NUMBERS: Penn's Fergus Couch evaluated the "actual prevelance of BRCA1 mutations" among 263 women with a family history of the disease. In the early days of the Human Genome Project, attention focused on rare disorders that strictly follow Mendel's laws of inheritance, recurring in predictable patterns within families. With many of these genes identified and mapped as the finish line nears, emphasis has shifted to genes that cause more common ills, particularly cancers, and the public has

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Fergus Couch
HARD NUMBERS: Penn's Fergus Couch evaluated the "actual prevelance of BRCA1 mutations" among 263 women with a family history of the disease.
In the early days of the Human Genome Project, attention focused on rare disorders that strictly follow Mendel's laws of inheritance, recurring in predictable patterns within families. With many of these genes identified and mapped as the finish line nears, emphasis has shifted to genes that cause more common ills, particularly cancers, and the public has become more aware of genetic testing. These conditions are transmitted in more complex ways; the complications are creating problems for technology transfer from the research lab to the clinic.

EDUCATION NEEDED: Johns Hopkins' Gloria Petersen found that many health care professionals misinterpret the results of genetic tests. The unexpected complexity of genetic testing technology is threatening its acceptance by consumers. "It is a very difficult situation. New discoveries attract publicity, and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ricki Lewis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution